Carolyn Short cofounded Himalaya and is its President & COO.  Ms. Short is also co-founder of BioAtla®, and was head of global intellectual property and business strategy for the company from inception through its’ successful IPO until May of 2021. While at BioAtla, prior to the IPO, she helped the company raise over $100M out of partnerships with Chinese biopharma companies and investors.  Ms. Short was head of the intellectual property group of Diversa Corporation (now BASF) from the company’s inception through her departure after that company’s successful IPO, the largest in biotech history at the time. At Diversa, she was part of the team that raised over $500M for the company.  Prior to Diversa, Ms. Short held roles in sales, business development, marketing and product management at Stratagene Cloning Systems (currently Agilent). She has decades of experience in business, intellectual property, and licensing/technology transfer matters in a variety of industries, including healthcare, life science, energy, industrial chemicals, agriculture, foods & flavors, diagnostics, research reagents and cleantech. She holds a degree in Biochemistry & Cell Biology from the University of California, San Diego, and is a registered patent agent with the United States Patent & Trademark Office.